AR023292A1 - Un compuesto derivado de imidazol, un procedimiento para su preparacion, y un medicamento y una composicion farmaceutica que comprende a dicho compuesto - Google Patents

Un compuesto derivado de imidazol, un procedimiento para su preparacion, y un medicamento y una composicion farmaceutica que comprende a dicho compuesto

Info

Publication number
AR023292A1
AR023292A1 ARP980105841A ARP980105841A AR023292A1 AR 023292 A1 AR023292 A1 AR 023292A1 AR P980105841 A ARP980105841 A AR P980105841A AR P980105841 A ARP980105841 A AR P980105841A AR 023292 A1 AR023292 A1 AR 023292A1
Authority
AR
Argentina
Prior art keywords
compound
pyridine
phenyl
alkyl
group
Prior art date
Application number
ARP980105841A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of AR023292A1 publication Critical patent/AR023292A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

Un compuesto derivado de imidazol de formula (1) en la cual: A representa un heterociclo, saturado o insaturado, que comprende un átomo de nitrogeno deformula (2), (3), (4) o (5): R1 y R2 representan, independientemente uno de otro, un hidrogeno, ungrupo C1-6 alquilo, o forman juntos un grupo polimetileno-(CH2)n-, pudiendo n tomar los valores de 3 a 6, R5 representa un fenilo o una 2-, 3- o 4-piridina, siendo el fenilo o la piridina sustituido por R3 y R3,donde R3 y R3 representan,independient emente uno de otro, un átomo de hidrogeno, de halogeno, un hidroxi, un grupo C1-4 alquilo o C1-6 alcoxi, R6 representaun fenilo o una 2-, 3- o 4-piridina, siendo el fenilo o la piridina sustituido por R4 y R4, donde R4 y R4representan, independient emente uno de otro, unátomo de hidrogeno, un halogeno, un hidroxi, un amino, un ciano, una sulfonamida, un aminocarbonilo, un trifluorometilo, un grupo C1-6 alcoxi,(di)hidroxi-C1-6alcoxi o C1-4 alquilo, y R7 representa unátomo de hidrogeno o un grup o C1-2 alquilo, en forma de enantiomero, de diastereoisomero o de mezcla de estasdiferentes formas, incluida la mezcla racémica así como sus derivados N-oxido y sus sales de adicion a ácidos farmacéuticamente aceptables.Un procedimientopara la prepa racion de este compuesto derivado, un medicamento constituido por este compuesto y una composicion farmacéutica que comprende al compuesto y uno ovarios excipientes apropiados. Los resultados de los tests biologicosdemuestran que el compuesto es un antagonista de los receptores muscarínicos M3 yserotoninérgicos 5-HT4. Por lo tanto puede ser utilizado en el tratamiento del síndrome del colon irritable, de los trastornos de la memoria, de la obstruccionde lasvías aéreas y de las inestabilidades vesicales, en particular la incontinencia urinaria de urgencia.
ARP980105841A 1997-11-19 1998-11-18 Un compuesto derivado de imidazol, un procedimiento para su preparacion, y un medicamento y una composicion farmaceutica que comprende a dicho compuesto AR023292A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714486A FR2771093B1 (fr) 1997-11-19 1997-11-19 Derives d'imidazole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR023292A1 true AR023292A1 (es) 2002-09-04

Family

ID=9513524

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105841A AR023292A1 (es) 1997-11-19 1998-11-18 Un compuesto derivado de imidazol, un procedimiento para su preparacion, y un medicamento y una composicion farmaceutica que comprende a dicho compuesto

Country Status (10)

Country Link
US (1) US6200991B1 (es)
EP (1) EP1032569A1 (es)
JP (1) JP2001523679A (es)
AR (1) AR023292A1 (es)
AU (1) AU1243399A (es)
CO (1) CO4990949A1 (es)
FR (1) FR2771093B1 (es)
TW (1) TW448170B (es)
WO (1) WO1999025710A1 (es)
ZA (1) ZA9810558B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805815B1 (fr) * 2000-03-01 2002-05-17 Sanofi Synthelabo Derives de polyfluoroalkylimidazole, leur preparation et leur application en therapeutique
FR2805816B1 (fr) * 2000-03-01 2002-05-17 Sanofi Synthelabo Derives d'haloimidazole, leur preparation et leur application en therapeutique
EP1326844A2 (en) * 2000-10-16 2003-07-16 Chugai Seiyaku Kabushiki Kaisha Process for preparation of n-substituted 2-sulfanylimidazoles
DE60224509T2 (de) * 2001-03-29 2009-03-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazolderivate verwendbar als histamin h3 rezeptorliganden
AU2003301184A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals Inc METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
EP1721607A1 (en) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
US20090156465A1 (en) * 2005-12-30 2009-06-18 Sattigeri Jitendra A Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
KR20080089461A (ko) 2005-12-30 2008-10-06 랜박시 래보러터리스 리미티드 무스카린 수용체 길항제
WO2008041184A2 (en) * 2006-10-03 2008-04-10 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US20100168197A1 (en) * 2007-02-28 2010-07-01 Naresh Kumar Muscarinic receptor antagonists
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
FR2747678B1 (fr) * 1996-04-22 1998-05-22 Synthelabo Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
FR2751647B1 (fr) * 1996-07-25 1998-09-11 Synthelabo Derives de benzimidazole, leurs preparations et leurs applications en therapeutique

Also Published As

Publication number Publication date
FR2771093A1 (fr) 1999-05-21
FR2771093B1 (fr) 2000-01-21
US6200991B1 (en) 2001-03-13
CO4990949A1 (es) 2000-12-26
ZA9810558B (en) 1999-05-18
JP2001523679A (ja) 2001-11-27
TW448170B (en) 2001-08-01
EP1032569A1 (fr) 2000-09-06
WO1999025710A1 (fr) 1999-05-27
AU1243399A (en) 1999-06-07

Similar Documents

Publication Publication Date Title
RU2388750C2 (ru) Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
AR037489A1 (es) Quinolinas sustituidas y proceso para su preparacion
AR066460A2 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
NO20072116L (no) Farmasoytiske forbindelser
PE20071009A1 (es) Compuestos derivados de fenoxipiperidinas como antagonistas de histamina h3
AR065556A1 (es) Derivados de 3-(( 1,2,4) triazolo (4,3-a) piridin -7-il) benzamida
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
NO20045103L (no) Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse
AR054799A1 (es) Derivados de oxindol
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
CO5590915A2 (es) Derivados de piperidina como antagonistas nk1 ( receptor del neuropeptido neuroquinina-1) con actividad antagonista superior en tratamientos de trastornos fisiologicos y disminucion de efectos colaterales
RU2013138834A (ru) N-[3-(5-амино-3,3а,7,7а-тетрагидро-1н-2,4-диокса-6-аза-инден-7-ил)-фенил]-амиды в качестве ингибиторов васе1 и(или) васе2
RU2012142171A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение в лечении психических расстройств
WO2007039781A3 (en) 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
RU2008129723A (ru) Ингибиторы ccr9 активности
RU2013154117A (ru) Производные 1-фенил-2-пиридинилалкильных спиртов в качестве ингибиторов фосфодиэстеразы
AR023292A1 (es) Un compuesto derivado de imidazol, un procedimiento para su preparacion, y un medicamento y una composicion farmaceutica que comprende a dicho compuesto
HRP20120424T1 (hr) Derivati ureje, postupci za njihovu proizvodnju i njihova uporaba
RU2006138663A (ru) Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
AR043658A1 (es) Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
RU2009139915A (ru) Производные имидазолидинона
RU2007128080A (ru) Производные пирролидиния в качестве мускариновых рецепторов мз

Legal Events

Date Code Title Description
FA Abandonment or withdrawal